1. Home
  2. |Professionals
  3. |Ryan Flynn

Ryan Flynn

Counsel
Counsel
cmZseW5uQGNyb3dlbGwuY29t
VCardLinkedIn
VCardLinkedIn

Areas of Focus

Overview

Ryan Flynn is a counsel in Crowell & Moring’s New York office and a member of both the Corporate and Transportation Groups. Ryan’s practice centers on mergers and acquisitions as well as general corporate and securities matters for public and private companies across a broad range of industries and business stages.

Ryan has significant experience advising clients on complex M&A transactions, including buy-side and sell-side acquisitions, divestitures, and strategic investments. He brings particular depth to clients operating in the government contracting sector, where he counsels on transactions and a full range of corporate matters unique to that industry. Ryan also maintains an active practice in the transportation sector, advising clients on corporate transactions, commercial contracting, and other business-critical matters.

Prior to joining the firm, Ryan was a member of the corporate and securities group of a New York-based law firm, where he mainly advised companies on general corporate governance matters, initial public offerings, PIPEs, follow-on offerings, and the various regulatory disclosures of the Securities Exchange Act of 1934.

Career & Education

    • Siena College, B.A., magna cum laude, 2018
    • Albany Law School, Accelerated J.D., cum laude, 2020
    • Siena College, B.A., magna cum laude, 2018
    • Albany Law School, Accelerated J.D., cum laude, 2020

    • New York
    • New York

Ryan's Insights

Firm News | 2 min read | 05.22.26

Crowell & Moring Represents Kanders & Company in Acquisition of Ginkgo Bioworks’ Biosecurity Business

May 22, 2026: A Crowell & Moring team represented Kanders & Company in a complex carveout transaction in which Kanders acquired the biosecurity business of publicly traded Ginkgo Bioworks. The resulting company, Perimeter Systems, has launched as the world’s first integrated biosecurity infrastructure platform, designed to transform biological signals into real-time intelligence and accelerate decisive response. At closing, Perimeter secured $60 million in growth capital, led by Kanders in partnership with SCS Financial, Goldcrest Capital, Four Cities Capital, and the Safe Artificial Intelligence Fund (SAIF)....

View All Insights

Representative Matters

  • Represented Kanders & Company in a complex carveout acquisition of the biosecurity business of publicly traded Ginkgo Bioworks, resulting in the formation of Perimeter Systems and the closing of an investment of growth capital financing.
  • Represented leading global apparel and footwear brands in connection with commercial contracting matters related to their respective international supply chains.
  • Represented Parsons Corporation in its $89 million acquisition of Chesapeake Technology International, a defense technology firm with advanced capabilities supporting all-domain operations and the Indo-Pacific Command.
  • Represented the founders of Aerial Armor in the sale of the company to Dedrone Holdings Inc., a leader in smart airport security, navigating a complex transaction spanning government contracting, tax, and employment matters.
  • Represented Firefly Aerospace in connection with its $75 million Series B preferred equity issuance and the secondary sale of equity to AE Industrial Partners LLP, transactions constituting a change of control of the company.
  • Represented a leading global investment bank in numerous transactions related to the purchase of tax credits.
  • Represented a family shareholder in the acquisition of a pet food company through three integrated transactions—a stock purchase triggered by a contested right of first refusal, a tax-efficient real estate acquisition, and a partnership and financing arrangement—all closed within a compressed ROFR timeframe.
  • Served as lead U.S. deal counsel in two significant cross-border precious metals transactions: (1) represented a Canadian copper and gold exploration company (CA$4 billion market cap) in a complex spinout distributing royalties on its Argentina and Chile copper and gold projects to a newly formed royalty company; and (2) represented a leading precious metals royalty streaming company in its pending $3.6 billion all-stock acquisition by a Denver-based precious metals royalty company—among the largest such transactions in history—including a related cross-border sale of an affiliated publicly traded copper company valued at approximately CA$195 million.
  • Represented Aptible, a provider of secure cloud infrastructure solutions, in its strategic combination with Opti9, a cloud solutions provider, to expand Aptible's managed cloud offerings and accelerate product innovation.
  • Represented Atomic Alchemy, Inc. in its $25 million acquisition by Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, to establish a domestic supply chain for high-value radioisotopes critical to healthcare, research, and defense sectors.
  • Represented Rekor Systems, Inc. (Nasdaq: REKR), a global AI technology company, in its $28.75 million firm-commitment underwritten public offering of common stock, including the exercise in full of the underwriters' over-allotment option.
  • Represented a leading health insurance and healthcare services company in the acquisition of numerous orthopedic practices.
  • Serves as outside general counsel to Rekor Systems, Inc. (NASDAQ:REKR) an AI technology company with a mission to provide data-driven insights that build safer, smarter and more efficient cities through intelligent infrastructure, including in connection with M&A transactions, fundraisings and other matters.

Ryan's Insights

Firm News | 2 min read | 05.22.26

Crowell & Moring Represents Kanders & Company in Acquisition of Ginkgo Bioworks’ Biosecurity Business

May 22, 2026: A Crowell & Moring team represented Kanders & Company in a complex carveout transaction in which Kanders acquired the biosecurity business of publicly traded Ginkgo Bioworks. The resulting company, Perimeter Systems, has launched as the world’s first integrated biosecurity infrastructure platform, designed to transform biological signals into real-time intelligence and accelerate decisive response. At closing, Perimeter secured $60 million in growth capital, led by Kanders in partnership with SCS Financial, Goldcrest Capital, Four Cities Capital, and the Safe Artificial Intelligence Fund (SAIF)....

View All Insights

Insights

Firm News | 2 min read | 05.22.26

Crowell & Moring Represents Kanders & Company in Acquisition of Ginkgo Bioworks’ Biosecurity Business

Firm News | 7 min read | 01.09.26

Crowell & Moring Elects 15 New Partners, Promotes One to Senior Counsel and 26 to Counsel

Firm News | 1 min read | 11.24.25

Crowell & Moring Represents Aptible in Strategic Combination With Opti9

Blog Post | 11.11.25

Big Data v. the Individual’s Right to Privacy on the Road

View All Insights

Practices

Industries

Ryan's Insights

Firm News | 2 min read | 05.22.26

Crowell & Moring Represents Kanders & Company in Acquisition of Ginkgo Bioworks’ Biosecurity Business

May 22, 2026: A Crowell & Moring team represented Kanders & Company in a complex carveout transaction in which Kanders acquired the biosecurity business of publicly traded Ginkgo Bioworks. The resulting company, Perimeter Systems, has launched as the world’s first integrated biosecurity infrastructure platform, designed to transform biological signals into real-time intelligence and accelerate decisive response. At closing, Perimeter secured $60 million in growth capital, led by Kanders in partnership with SCS Financial, Goldcrest Capital, Four Cities Capital, and the Safe Artificial Intelligence Fund (SAIF)....

View All Insights